Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 38

1.

Phospholipid transfer protein deficiency in mice impairs macrophage reverse cholesterol transport in vivo.

Si Y, Zhang Y, Chen X, Zhai L, Zhou G, Yu A, Cao H, Shucun Q.

Exp Biol Med (Maywood). 2016 Jul;241(13):1466-72. doi: 10.1177/1535370216641218. Epub 2016 Mar 31.

2.

Insulin Dissociates the Effects of Liver X Receptor on Lipogenesis, Endoplasmic Reticulum Stress, and Inflammation.

Sun X, Haas ME, Miao J, Mehta A, Graham MJ, Crooke RM, Pais de Barros JP, Wang JG, Aikawa M, Masson D, Biddinger SB.

J Biol Chem. 2016 Jan 15;291(3):1115-22. doi: 10.1074/jbc.M115.668269. Epub 2015 Oct 28.

3.

Liver X receptors at the intersection of lipid metabolism and atherogenesis.

Lee SD, Tontonoz P.

Atherosclerosis. 2015 Sep;242(1):29-36. doi: 10.1016/j.atherosclerosis.2015.06.042. Epub 2015 Jul 2. Review. No abstract available.

4.

A computational model for the analysis of lipoprotein distributions in the mouse: translating FPLC profiles to lipoprotein metabolism.

Sips FL, Tiemann CA, Oosterveer MH, Groen AK, Hilbers PA, van Riel NA.

PLoS Comput Biol. 2014 May 1;10(5):e1003579. doi: 10.1371/journal.pcbi.1003579. eCollection 2014 May.

5.

The macrophage LBP gene is an LXR target that promotes macrophage survival and atherosclerosis.

Sallam T, Ito A, Rong X, Kim J, van Stijn C, Chamberlain BT, Jung ME, Chao LC, Jones M, Gilliland T, Wu X, Su GL, Tangirala RK, Tontonoz P, Hong C.

J Lipid Res. 2014 Jun;55(6):1120-30. doi: 10.1194/jlr.M047548. Epub 2014 Mar 26.

6.

Phospholipid transfer protein is expressed in cerebrovascular endothelial cells and involved in high density lipoprotein biogenesis and remodeling at the blood-brain barrier.

Chirackal Manavalan AP, Kober A, Metso J, Lang I, Becker T, Hasslitzer K, Zandl M, Fanaee-Danesh E, Pippal JB, Sachdev V, Kratky D, Stefulj J, Jauhiainen M, Panzenboeck U.

J Biol Chem. 2014 Feb 21;289(8):4683-98. doi: 10.1074/jbc.M113.499129. Epub 2013 Dec 25.

7.

Identification of biological markers of liver X receptor (LXR) activation at the cell surface of human monocytes.

Rébé C, Filomenko R, Raveneau M, Chevriaux A, Ishibashi M, Lagrost L, Junien JL, Gambert P, Masson D.

PLoS One. 2012;7(11):e48738. doi: 10.1371/journal.pone.0048738. Epub 2012 Nov 21.

8.

The impact of phospholipid transfer protein (PLTP) on lipoprotein metabolism.

Jiang XC, Jin W, Hussain MM.

Nutr Metab (Lond). 2012 Aug 16;9(1):75. doi: 10.1186/1743-7075-9-75.

9.

Reproducible isolation of lymph node stromal cells reveals site-dependent differences in fibroblastic reticular cells.

Fletcher AL, Malhotra D, Acton SE, Lukacs-Kornek V, Bellemare-Pelletier A, Curry M, Armant M, Turley SJ.

Front Immunol. 2011 Sep 12;2:35. doi: 10.3389/fimmu.2011.00035. eCollection 2011.

10.

Cholesterol efflux and atheroprotection: advancing the concept of reverse cholesterol transport.

Rosenson RS, Brewer HB Jr, Davidson WS, Fayad ZA, Fuster V, Goldstein J, Hellerstein M, Jiang XC, Phillips MC, Rader DJ, Remaley AT, Rothblat GH, Tall AR, Yvan-Charvet L.

Circulation. 2012 Apr 17;125(15):1905-19. doi: 10.1161/CIRCULATIONAHA.111.066589. Review. No abstract available.

11.

Biliary and nonbiliary contributions to reverse cholesterol transport.

Temel RE, Brown JM.

Curr Opin Lipidol. 2012 Apr;23(2):85-90. doi: 10.1097/MOL.0b013e3283508c21. Review.

12.

P-glycoprotein dysfunction contributes to hepatic steatosis and obesity in mice.

Foucaud-Vignault M, Soayfane Z, Ménez C, Bertrand-Michel J, Martin PG, Guillou H, Collet X, Lespine A.

PLoS One. 2011;6(9):e23614. doi: 10.1371/journal.pone.0023614. Epub 2011 Sep 16.

13.

LXR agonist increases apoE secretion from HepG2 spheroid, together with an increased production of VLDL and apoE-rich large HDL.

Kurano M, Iso-O N, Hara M, Ishizaka N, Moriya K, Koike K, Tsukamoto K.

Lipids Health Dis. 2011 Aug 5;10:134. doi: 10.1186/1476-511X-10-134.

14.

Role of plasma phospholipid transfer protein in lipid and lipoprotein metabolism.

Albers JJ, Vuletic S, Cheung MC.

Biochim Biophys Acta. 2012 Mar;1821(3):345-57. doi: 10.1016/j.bbalip.2011.06.013. Epub 2011 Jun 28. Review.

15.

Role of phospholipid transfer protein in high-density lipoprotein- mediated reverse cholesterol transport.

Yazdanyar A, Yeang C, Jiang XC.

Curr Atheroscler Rep. 2011 Jun;13(3):242-8. doi: 10.1007/s11883-011-0172-5. Review.

16.

Coronary heart disease: Significance of liver X receptor α genomics.

Dave VP, Kaul D.

World J Cardiol. 2010 Jun 26;2(6):140-9. doi: 10.4330/wjc.v2.i6.140.

17.
18.

Increased expression of RXRα in dementia: an early harbinger for the cholesterol dyshomeostasis?

Akram A, Schmeidler J, Katsel P, Hof PR, Haroutunian V.

Mol Neurodegener. 2010 Sep 15;5:36. doi: 10.1186/1750-1326-5-36.

19.

Diet-induced lipid accumulation in phospholipid transfer protein-deficient mice: its atherogenicity and potential mechanism.

Yeang C, Qin S, Chen K, Wang DQ, Jiang XC.

J Lipid Res. 2010 Oct;51(10):2993-3002. doi: 10.1194/jlr.M007088. Epub 2010 Jun 11.

20.

Altered phospholipid transfer protein gene expression and serum lipid profile by topotecan.

Saunders RA, Fujii K, Alabanza L, Ravatn R, Kita T, Kudoh K, Oka M, Chin KV.

Biochem Pharmacol. 2010 Aug 1;80(3):362-9. doi: 10.1016/j.bcp.2010.04.015. Epub 2010 Apr 21.

Supplemental Content

Support Center